What is included in patient education about Burkitt lymphoma/Burkitt-like lymphoma (BL/BLL)?

Updated: Dec 20, 2019
  • Author: Ali H Kanbar, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Provide information and support about the disease and the adverse effects of the drugs used to treat Burkitt lymphoma (BL) to patients and the family members, such as the following:

  • Secondary leukemias and myelodysplastic syndrome
  • Infertility
  • Possible anaphylactic reactions
  • Serious and potentially fatal infections

Inform patients who require high-dose chemotherapy and stem-cell transplantation that long-term complications of higher doses of chemoradiotherapy and a mortality rate of 3-5% from the conditioning regimen are possible

Young patients should be referred for counseling regarding fertility preservation, before chemotherapy, if possible.

Clearly explain transfusions (both red blood cells and platelets) and their associated complications.

Emotional support is very helpful to patients with cancer. Educating the medical personnel directly involved in patient care and the family members about emotional support for the patient is very important.

Patients should also be educated about the following:

  • Febrile neutropenia
  • Postchemotherapy thrombocytopenia and the tendency to bleed with minimal trauma
  • Chemotherapy-associated alopecia
  • Avoidance of pregnancy in women of childbearing age
  • Chemotherapy-induced nausea and vomiting
  • Chemotherapy-associated menstrual dysregulation (females) and the possibility of sexual dysfunction
  • Fatigue
  • Sperm banking

For patient education information, see the Lymphoma Directory and Burkitt Lymphoma.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!